Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Retained Earnings (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Retained Earnings data on record, last reported at $563000.0 in Q4 2025.

  • For Q4 2025, Retained Earnings rose 100.07% year-over-year to $563000.0; the TTM value through Dec 2025 reached $563000.0, up 100.07%, while the annual FY2025 figure was $563000.0, 100.07% up from the prior year.
  • Retained Earnings reached $563000.0 in Q4 2025 per PRAX's latest filing, up from $500000.0 in the prior quarter.
  • Across five years, Retained Earnings topped out at $1.3 million in Q3 2024 and bottomed at -$977.2 million in Q2 2025.
  • Average Retained Earnings over 4 years is -$395.9 million, with a median of -$467.5 million recorded in 2022.
  • Peak YoY movement for Retained Earnings: surged 100.21% in 2024, then crashed 1376238.03% in 2025.
  • A 4-year view of Retained Earnings shows it stood at -$173000.0 in 2022, then tumbled by 362352.6% to -$627.0 million in 2023, then crashed by 33.44% to -$836.7 million in 2024, then skyrocketed by 100.07% to $563000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were $563000.0 in Q4 2025, $500000.0 in Q3 2025, and -$977.2 million in Q2 2025.